[Therapeutic management of non-valvular atrial fibrillation. Update 2013]

K Bode1, P Sommer, A Bollmann

  • 1Abteilung für Rhythmologie, Herzzentrum Leipzig, Universität Leipzig, Strümpellstr. 39, 04289, Leipzig, Deutschland, kerstin.bode@med.uni-leipzig.de.

Herz
|September 26, 2013
PubMed

Insights

Atrial fibrillation affects 10% of elderly individuals in western countries. Management focuses on preventing blood clots and controlling heart rate or rhythm to improve patient well-being.

Area of Science:

  • Cardiology
  • Geriatrics
  • Internal Medicine

Context:

  • Atrial fibrillation (AF) is a common condition affecting 10% of individuals over 65 in western countries.
  • Effective management of AF is crucial for preventing thromboembolic complications and cardiovascular comorbidities.

Purpose:

  • To outline current therapeutic strategies for atrial fibrillation, focusing on anticoagulation and symptom management.
  • To highlight the importance of individual risk assessment (e.g., CHA2DS2-Vasc score) in guiding AF treatment.
  • To discuss rate and rhythm control strategies for alleviating AF-related symptoms.

Summary:

  • Therapy for atrial fibrillation prioritizes thromboembolic prophylaxis via anticoagulation, tailored to patient risk scores like CHA2DS2-Vasc.
  • Symptom management involves rate control (resting heart rate <110/min) or rhythm control (cardioversion, antiarrhythmic drugs, catheter ablation).
  • The long-term prognostic benefit of maintaining sinus rhythm in AF patients remains under investigation in ongoing clinical trials.

Impact:

  • Provides a concise overview of current atrial fibrillation management guidelines.
  • Emphasizes the individualized approach to anticoagulation and symptom control in elderly patients.
  • Informs clinicians and researchers about the ongoing evaluation of rhythm control strategies for improving AF patient outcomes.

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...